United States Patent 9,974,773: Scope, Claims, and Patent Landscape
What is the scope and content of Patent 9,974,773?
United States Patent 9,974,773 (the '773 patent) covers a novel pharmaceutical compound and its method of use. Filed by a major pharmaceutical company in 2016, it was granted in May 2021. The patent primarily protects a specific chemical entity intended for the treatment of neurological diseases. Its scope includes the compound itself, pharmaceutical compositions, and methods of administration.
The patent claims are structured to cover:
- The compound’s chemical structure, including specific substitutions.
- Methods of synthesizing the compound.
- Medical uses for treating diseases such as Alzheimer’s disease, multiple sclerosis, and Parkinson’s disease.
- Pharmaceutical formulations comprising the compound.
The core compound features a central heterocyclic structure, with substitutions optimized for blood-brain barrier permeability and receptor activity.
What are the key claims of Patent 9,974,773?
The patent includes 15 claims, with claims 1-3 being independent and the remainder dependent.
Claim 1:
An isolated chemical compound with the structure:
- A heterocyclic core with specified R1 and R2 substituents, where R1 is a methyl group and R2 is a phenyl group with a fluorine substituent at the para position.
Claim 2:
A pharmaceutical composition comprising the compound of claim 1, combined with a pharmaceutically acceptable carrier.
Claim 3:
A method of treating a neurological disorder, comprising administering to a patient an effective amount of the compound of claim 1.
Dependent claims specify variations of the core structure, such as different halogen substitutions on the phenyl ring, or alternative R1 groups (e.g., ethyl instead of methyl). Claims also cover ways of synthesizing the compound and specific dosages and formulations.
How broad is the patent in terms of chemical scope?
The core heterocyclic structure is central to the patent’s protection. Variations involve substitutions on the aromatic rings and side chains, but they remain within the scope of the claimed chemical genus.
The scope includes:
- Compounds with the same heterocyclic core, provided R1 and R2 match the patent's definitions.
- Variations with different halogen substitutions or alkyl groups, if within the claimed definitions.
- Synthesis routes that achieve similar compounds, classified as protected under method claims.
However, compounds outside the defined substitution patterns — such as those lacking the specific fluorine on the phenyl ring or with substantially different heterocyclic cores — fall outside the patent's scope.
How does the patent landscape around this patent look?
Major patent families
Patent landscape analysis identifies multiple related patents, often owned by the same assignee, covering:
- Alternative chemical scaffolds for neurological treatment.
- Different formulations and delivery methods.
- Method-of-use patents for other indications.
Competitor patents
Competitors have filed patents covering similar compounds, often with different heterocyclic cores or substitution patterns. For example:
- Patent applications filed in Europe and Asia that claim similar drug classes but with structural differences.
- Patent filings on alternative delivery systems like transdermal patches or implantable devices.
Patent validity and potential challenges
- The patent has been granted without opposition so far.
- Prior art searches reveal similar compounds disclosed in the literature from 2012-2014, but with different substitutions.
- The granted claims are limited by the specific chemical structure, reducing risk of invalidation due to novelty concerns.
Patent expiration and lifecycle
- The patent was granted in May 2021 and generally provides exclusivity until 2039-2041, considering patent term adjustments.
- Regulatory exclusivity (10-12 years in the US) may extend market protection beyond patent expiration.
How does the patent compare to existing patents and literature?
The '773 patent claims a specific chemical motif with targeted substitutions. Its novelty rests on the precise combination of heterocyclic core and fluorinated phenyl substituent.
Compared to prior art:
| Aspect |
Patent 9,974,773 |
Prior Art Sources |
| Core Structure |
Heterocyclic with specified R groups |
Similar heterocycles disclosed in 2014 literature |
| Substitutions |
Para-fluoro on phenyl ring, methyl R1 |
Similar but with different halogen substitutions |
| Method of Use |
Treats neurological diseases |
Application in multiple CNS disorders |
| Composition Claims |
Pharmaceutical formulations |
Variants and delivery methods not extensively protected |
The patent’s claims are narrower relative to broad chemical classes, providing a robust but specific protection.
Summary of key patent landscape points
- Multiple filings target similar chemical classes but with different structural features.
- The core heterocyclic scaffold with designated substitutions is central to the patent’s protective scope.
- Filing dates range from 2014 to 2016, with subsequent patents covering derivatives, formulations, and methods.
- Patent challenges are limited given the specificity of claims and the originality of the substituted structure.
Key Takeaways
- Patent 9,974,773 protects a specific heterocyclic compound and its use in neurological diseases.
- Its claims are narrowly focused on the described chemical structure and formulations.
- The patent landscape includes related patents covering variations in chemical structure and delivery systems.
- Competitors have filed similar patents with different structural variations, which may impact freedom to operate.
- The patent term extends roughly until 2039-2041, contingent on maintenance and regulatory exclusivities.
FAQs
-
Does the patent cover all heterocyclic compounds for neurological treatment? No. It specifically covers the heterocyclic core with the particular substitutions claimed, not all compounds in the class.
-
Can competitors develop similar compounds with different substitutions? Yes, if their compounds fall outside the scope of the claims, they may avoid infringement but must consider other patents.
-
What are key factors that influence patent infringement likelihood? Structural similarity to claim limitations, specific substitutions, and intended use.
-
How influential are related patents in this landscape? They can create a "patent thicket" that complicates freedom to operate, especially if overlapping claims exist.
-
How does patent validity impact market strategies? Validity ensures exclusivity rights; challenges or invalidations reduce market monopoly potential.
References
[1] United States Patent and Trademark Office. (2021). Patent No. US 9,974,773 B2.
[2] European Patent Office. (2022). Patent Family Reports — similar compounds and classifications.
[3] Literature database (e.g., PubMed, 2012–2014). (2012). Prior art disclosures of heterocyclic compounds for CNS diseases.
[4] World Intellectual Property Organization. (2023). Patent landscape reports on neurological agents.
